Services: Diversified Services

Genetic Technologies Ltd (GENE: NASDAQ)

$0.403 0.0631 | 18.56%
11/25/14 - 04:00 PM ET
Company Income Statement
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Sales 5.22M 7.78M 11.60M 19.53M
Cost of Sales 1.41M 1.44M 1.42M 1.52M
Gross Operating Profit 3.81M 6.34M 10.18M 18.02M
Selling, General, and Administrative Expenses 9.89M 11.21M 11.53M 11.56M
Research & Development 3.11M 3.21M 4.13M 4.68M
Operating Income before D & A (EBITDA) -9.19M -8.08M -5.47M 1.78M
Depreciation & Amortization 318.64K 369.59K 575.48K 659.29K
Interest Income 0.00 0.00 624.50K 0.00
Other Income - Net 1.01M 218.51K 46.75K -68.62K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -8.84M -8.64M -5.38M 1.05M
Interest Expense 700.66K 36.16K 46.31K 87.57K
Pre-Tax Income -9.54M -8.68M -5.42M 963.32K
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest -8.73K -47.43K -9.53K -9.26K
Net Income From Continuing Operations -9.54M -8.68M -5.42M 963.32K
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -9.54M -8.68M -5.42M 963.32K
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -9.53M -8.63M -5.41M 972.58K
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-9.54M -8.68M -5.42M 963.32K
Preferred Dividends
Net Income Available To Common -9.54M -8.68M -5.42M 963.32K
Basic EPS from Continuing Ops. -0.50 -0.55 -0.35 0.07
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.50 -0.55 -0.35 0.07
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.50 -0.55 -0.35 0.07
Basic Normalized Net Income/Share -0.50 -0.55 -0.35 0.07
EPS fr Continuing Ops. -0.50 -0.55 -0.35 0.07
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.50 -0.55 -0.35 0.07
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.50 -0.55 -0.35 0.07
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.50 -0.55 -0.35 0.07
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GENE

Latest GENE Headlines from TheStreet

More Financial News for GENE

Press Releases for GENE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter